Puma Biotechnology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBYI and other ETFs, options, and stocks.

About PBYI

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. 

CEO
Alan H. Auerbach
CEOAlan H. Auerbach
Employees
179
Employees179
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
2010
Founded2010
Employees
179
Employees179

PBYI Key Statistics

Market cap
444.62M
Market cap444.62M
Price-Earnings ratio
16.11
Price-Earnings ratio16.11
Dividend yield
Dividend yield
Average volume
277.04K
Average volume277.04K
High today
$9.40
High today$9.40
Low today
$8.12
Low today$8.12
Open price
$8.16
Open price$8.16
Volume
417.08K
Volume417.08K
52 Week high
$9.40
52 Week high$9.40
52 Week low
$3.05
52 Week low$3.05

Stock Snapshot

With a market cap of 444.62M, Puma Biotechnology(PBYI) trades at $8.27. The stock has a price-to-earnings ratio of 16.11.

As of 2026-08-07, Puma Biotechnology(PBYI) stock has fluctuated between $8.12 and $9.40. The current price stands at $8.27, placing the stock +1.9% above today's low and -12.0% off the high.

Puma Biotechnology(PBYI) shares are trading with a volume of 417.08K, against a daily average of 277.04K.

During the past year, Puma Biotechnology(PBYI) stock moved between $3.05 at its lowest and $9.40 at its peak.

During the past year, Puma Biotechnology(PBYI) stock moved between $3.05 at its lowest and $9.40 at its peak.

PBYI News

TipRanks 4h
Puma Biotechnology price target raised to $6 from $5 at TD Cowen

TD Cowen analyst Marc Frahm raised the firm’s price target on Puma Biotechnology (PBYI) to $6 from $5 and keeps a Hold rating on the shares. The firm updated it...

Investing.com 19h
Puma Biotech earnings beat by $0.16, revenue topped estimates - Investing.com

...

Puma Biotech earnings beat by $0.16, revenue topped estimates - Investing.com
TipRanks 21h
Puma Biotechnology reports Q2 EPS 19c vs 15c last year

Reports Q2 revenue $56.5M vs $52.4M last year. “We are pleased with our commercial execution in the second quarter and the continued increase in year-over-year...

People also own

Based on the portfolios of people who own PBYI. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.